Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.

Moccia M, Tajani A, Acampora R, Signoriello E, Corbisiero G, Vercellone A, Sergianni P, Pennino F, Lanzillo R, Palladino R, Capacchione A, Brescia Morra V, Lus G, Triassi M.

PLoS One. 2019 Sep 19;14(9):e0222012. doi: 10.1371/journal.pone.0222012. eCollection 2019.

2.

A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a.

Piacenti V, Langella E, Autiero I, Nolan JC, Piskareva O, Adamo MFA, Saviano M, Moccia M.

Bioorg Chem. 2019 Oct;91:103165. doi: 10.1016/j.bioorg.2019.103165. Epub 2019 Aug 3.

PMID:
31419642
3.

Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral.

Moccia M, Prados F, Filippi M, Rocca MA, Valsasina P, Brownlee WJ, Zecca C, Gallo A, Rovira A, Gass A, Palace J, Lukas C, Vrenken H, Ourselin S, Gandini Wheeler-Kingshott CAM, Ciccarelli O, Barkhof F; MAGNIMS Study Group.

Ann Neurol. 2019 Aug 6. doi: 10.1002/ana.25571. [Epub ahead of print]

PMID:
31385358
4.

Periodontal bacterial supernatants modify differentiation, migration and inflammatory cytokine expression in human periodontal ligament stem cells.

Ramenzoni LL, Russo G, Moccia MD, Attin T, Schmidlin PR.

PLoS One. 2019 Jul 3;14(7):e0219181. doi: 10.1371/journal.pone.0219181. eCollection 2019.

5.

Fatigue in multiple sclerosis: The role of thalamus.

Capone F, Collorone S, Cortese R, Di Lazzaro V, Moccia M.

Mult Scler. 2019 May 29:1352458519851247. doi: 10.1177/1352458519851247. [Epub ahead of print]

PMID:
31138052
6.

Advances in spinal cord imaging in multiple sclerosis.

Moccia M, Ruggieri S, Ianniello A, Toosy A, Pozzilli C, Ciccarelli O.

Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419840593. doi: 10.1177/1756286419840593. eCollection 2019. Review.

7.

Correction to: Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and education.

Falco F, Moccia M, Chiodi A, Carotenuto A, D'Amelio A, Rosa L, Piscopo K, Falco A, Costabile T, Lauro F, Brescia Morra V, Lanzillo R.

Neurol Sci. 2019 May;40(5):1099-1100. doi: 10.1007/s10072-019-03880-w.

PMID:
30949781
8.

Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.

Moccia M, Capacchione A, Lanzillo R, Carbone F, Micillo T, Perna F, De Rosa A, Carotenuto A, Albero R, Matarese G, Palladino R, Brescia Morra V.

Ther Adv Neurol Disord. 2019 Feb 18;12:1756286418819074. doi: 10.1177/1756286418819074. eCollection 2019.

9.

Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and education.

Falco F, Moccia M, Chiodi A, Carotenuto A, D'Amelio A, Rosa L, Piscopo K, Falco A, Costabile T, Lauro F, Brescia Morra V, Lanzillo R.

Neurol Sci. 2019 Apr;40(4):713-717. doi: 10.1007/s10072-019-3712-3. Epub 2019 Jan 15. Erratum in: Neurol Sci. 2019 Apr 5;:.

PMID:
30645750
10.

Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin.

Lanzillo R, Moccia M, Russo CV, Carotenuto A, Nozzolillo A, Petruzzo M, Palladino R, Chataway J, Brescia Morra V.

Mult Scler Relat Disord. 2019 Feb;28:193-196. doi: 10.1016/j.msard.2018.12.042. Epub 2019 Jan 2.

PMID:
30623857
11.

MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis.

Cocozza S, Pontillo G, Lanzillo R, Russo C, Petracca M, Di Stasi M, Paolella C, Vola EA, Criscuolo C, Moccia M, Lamberti A, Monti S, Brescia Morra V, Elefante A, Palma G, Tedeschi E, Brunetti A.

Neuroradiology. 2019 Feb;61(2):155-162. doi: 10.1007/s00234-018-02150-4. Epub 2019 Jan 8.

PMID:
30617409
12.

Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.

Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M.

J Neurol. 2019 Feb;266(2):361-368. doi: 10.1007/s00415-018-9139-6. Epub 2018 Nov 29.

PMID:
30498912
13.

Time to reconsider urate: Neuroprotective potential may prevail on cardiovascular risk in animal models and clinical trials.

Petruzzo M, Moccia M.

EBioMedicine. 2018 Nov;37:5-6. doi: 10.1016/j.ebiom.2018.10.073. Epub 2018 Nov 19. No abstract available.

14.

Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.

Carotenuto A, Costabile T, Moccia M, Falco F, Scala MR, Russo CV, Saccà F, De Rosa A, Lanzillo R, Brescia Morra V.

Mult Scler Relat Disord. 2019 Jan;27:1-6. doi: 10.1016/j.msard.2018.09.024. Epub 2018 Sep 22.

PMID:
30273697
15.

e-Health and multiple sclerosis: An update.

Lavorgna L, Brigo F, Moccia M, Leocani L, Lanzillo R, Clerico M, Abbadessa G, Schmierer K, Solaro C, Prosperini L, Tedeschi G, Giovannoni G, Bonavita S.

Mult Scler. 2018 Nov;24(13):1657-1664. doi: 10.1177/1352458518799629. Epub 2018 Sep 19.

PMID:
30231004
16.

Retinal vascular density in multiple sclerosis: a 1-year follow-up.

Lanzillo R, Cennamo G, Moccia M, Criscuolo C, Carotenuto A, Frattaruolo N, Sparnelli F, Melenzane A, Lamberti A, Servillo G, Tranfa F, De Crecchio G, Brescia Morra V.

Eur J Neurol. 2019 Jan;26(1):198-201. doi: 10.1111/ene.13770. Epub 2018 Sep 3.

PMID:
30102834
17.

Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis.

Lavorgna L, De Stefano M, Sparaco M, Moccia M, Abbadessa G, Montella P, Buonanno D, Esposito S, Clerico M, Cenci C, Trojsi F, Lanzillo R, Rosa L, Morra VB, Ippolito D, Maniscalco G, Bisecco A, Tedeschi G, Bonavita S.

Mult Scler Relat Disord. 2018 Oct;25:175-178. doi: 10.1016/j.msard.2018.07.046. Epub 2018 Jul 31.

PMID:
30096683
18.

Suboptimal Coding Metasurfaces for Terahertz Diffuse Scattering.

Moccia M, Koral C, Papari GP, Liu S, Zhang L, Wu RY, Castaldi G, Cui TJ, Galdi V, Andreone A.

Sci Rep. 2018 Aug 9;8(1):11908. doi: 10.1038/s41598-018-30375-z.

19.

Notch3 protein expression in skin fibroblasts from CADASIL patients.

Qualtieri A, Ungaro C, Bagalà A, Bianchi S, Pantoni L, Moccia M, Mazzei R.

J Neurol Sci. 2018 Jul 15;390:121-128. doi: 10.1016/j.jns.2018.04.027. Epub 2018 Apr 19.

PMID:
29801872
20.

Neurology and the Internet: a review.

Moccia M, Brigo F, Tedeschi G, Bonavita S, Lavorgna L.

Neurol Sci. 2018 Jun;39(6):981-987. doi: 10.1007/s10072-018-3339-9. Epub 2018 Mar 28. Review.

PMID:
29594831
21.

Optical coherence tomography angiography detects retinal vascular alterations in different phases of multiple sclerosis.

Lanzillo R, Moccia M, Criscuolo C, Cennamo G.

Mult Scler. 2019 Feb;25(2):300-301. doi: 10.1177/1352458518768060. Epub 2018 Mar 28. No abstract available.

PMID:
29587576
22.

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

Lanzillo R, Prosperini L, Gasperini C, Moccia M, Fantozzi R, Tortorella C, Nociti V, Annovazzi P, Cavalla P, Radaelli M, Malucchi S, Clerici VT, Boffa L, Buttari F, Ragonese P, Maniscalco GT, Di Filippo M, Buscarinu MC, Pinardi F, Gallo A, Coghe G, Pesci I, Laroni A, Gajofatto A, Calabrese M, Tomassini V, Cocco E, Solaro C; R.I.Re.MS study group.

J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.

PMID:
29549468
23.

Why do people search Wikipedia for information on multiple sclerosis?

Brigo F, Lattanzi S, Bragazzi N, Nardone R, Moccia M, Lavorgna L.

Mult Scler Relat Disord. 2018 Feb;20:210-214. doi: 10.1016/j.msard.2018.02.001. Epub 2018 Feb 5.

PMID:
29428464
24.

Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.

Tur C, Moccia M, Barkhof F, Chataway J, Sastre-Garriga J, Thompson AJ, Ciccarelli O.

Nat Rev Neurol. 2018 Feb;14(2):75-93. doi: 10.1038/nrneurol.2017.171. Epub 2018 Jan 12. Review.

PMID:
29326424
25.

Cardiovascular profile improvement during Natalizumab treatment.

Moccia M, Albero R, Lanzillo R, Saccà F, De Rosa A, Russo CV, Carotenuto A, Palladino R, Brescia Morra V.

Metab Brain Dis. 2018 Jun;33(3):981-986. doi: 10.1007/s11011-017-0169-z. Epub 2017 Dec 18.

26.

A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosis.

Moccia M, Palladino R, Carotenuto A, Saccà F, Russo CV, Lanzillo R, Brescia Morra V.

Mult Scler Relat Disord. 2018 Jan;19:50-54. doi: 10.1016/j.msard.2017.11.006. Epub 2017 Nov 6.

PMID:
29128737
27.

Imaging outcome measures for progressive multiple sclerosis trials.

Moccia M, de Stefano N, Barkhof F.

Mult Scler. 2017 Oct;23(12):1614-1626. doi: 10.1177/1352458517729456. Review. Erratum in: Mult Scler. 2018 Feb;24(2):NP32.

28.

Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis.

Lanzillo R, Cennamo G, Criscuolo C, Carotenuto A, Velotti N, Sparnelli F, Cianflone A, Moccia M, Brescia Morra V.

Mult Scler. 2018 Nov;24(13):1706-1714. doi: 10.1177/1352458517729463. Epub 2017 Sep 21.

PMID:
28933233
29.

Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a.

Lanzillo R, Carbone F, Quarantelli M, Bruzzese D, Carotenuto A, De Rosa V, Colamatteo A, Micillo T, De Luca Picione C, Saccà F, De Rosa A, Moccia M, Brescia Morra V, Matarese G.

Clin Immunol. 2017 Oct;183:249-253. doi: 10.1016/j.clim.2017.08.011. Epub 2017 Aug 18.

PMID:
28823971
30.

CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients.

Carotenuto A, Scalia G, Ausiello F, Moccia M, Russo CV, Saccà F, De Rosa A, Criscuolo C, Del Vecchio L, Brescia Morra V, Lanzillo R.

J Neuroimmunol. 2017 Aug 15;309:47-50. doi: 10.1016/j.jneuroim.2017.05.006. Epub 2017 May 12.

PMID:
28601287
31.

Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study.

Lavorgna L, Moccia M, Russo A, Palladino R, Riccio L, Lanzillo R, Brescia Morra V, Tedeschi G, Bonavita S.

Mult Scler Relat Disord. 2017 Apr;13:28-32. doi: 10.1016/j.msard.2017.02.001. Epub 2017 Feb 5.

32.

Molecular and Metabolic Imaging in Multiple Sclerosis.

Moccia M, Ciccarelli O.

Neuroimaging Clin N Am. 2017 May;27(2):343-356. doi: 10.1016/j.nic.2016.12.005. Review.

PMID:
28391791
33.

The importance of being persistent to multiple sclerosis treatments.

Moccia M, Lanzillo R, Cerullo G, De Rosa A, Brescia Morra V.

J Clin Neurosci. 2017 Jun;40:198-199. doi: 10.1016/j.jocn.2017.02.004. Epub 2017 Feb 27. No abstract available.

PMID:
28246007
34.

Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015.

Moccia M, Palladino R, Lanzillo R, Carotenuto A, Russo CV, Triassi M, Brescia Morra V.

PLoS One. 2017 Jan 5;12(1):e0169489. doi: 10.1371/journal.pone.0169489. eCollection 2017.

35.

Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis.

Lanzillo R, Di Somma C, Quarantelli M, Carotenuto A, Pivonello C, Moccia M, Cianflone A, Marsili A, Puorro G, Saccà F, Russo CV, De Luca Picione C, Ausiello F, Colao A, Brescia Morra V.

Eur J Neurol. 2017 Feb;24(2):446-449. doi: 10.1111/ene.13207. Epub 2016 Dec 16.

PMID:
27982500
36.

A longitudinal real-life comparison study of natalizumab and fingolimod.

Lanzillo R, Carotenuto A, Moccia M, Saccà F, Russo CV, Massarelli M, De Rosa A, Brescia Morra V.

Acta Neurol Scand. 2017 Sep;136(3):217-222. doi: 10.1111/ane.12718. Epub 2016 Dec 15.

PMID:
27976804
37.

Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis.

Moccia M, Palladino R, Carotenuto A, Russo CV, Triassi M, Lanzillo R, Brescia Morra V.

Mult Scler Relat Disord. 2016 Nov;10:90-96. doi: 10.1016/j.msard.2016.09.011. Epub 2016 Sep 28.

PMID:
27919507
38.

The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests.

Saccà F, Costabile T, Carotenuto A, Lanzillo R, Moccia M, Pane C, Russo CV, Barbarulo AM, Casertano S, Rossi F, Signoriello E, Lus G, Brescia Morra V.

Mult Scler. 2017 Aug;23(9):1289-1296. doi: 10.1177/1352458516677592. Epub 2016 Nov 3.

PMID:
27811338
39.

Caffeine consumption and the 4-year progression of de novo Parkinson's disease.

Moccia M, Erro R, Picillo M, Vitale C, Longo K, Amboni M, Pellecchia MT, Barone P.

Parkinsonism Relat Disord. 2016 Nov;32:116-119. doi: 10.1016/j.parkreldis.2016.08.005. Epub 2016 Aug 4.

PMID:
27622969
40.

Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.

Moccia M, Quarantelli M, Lanzillo R, Cocozza S, Carotenuto A, Carotenuto B, Alfano B, Prinster A, Triassi M, Nardone A, Palladino R, Brunetti A, Brescia Morra V.

Eur J Neurol. 2017 Jan;24(1):195-204. doi: 10.1111/ene.13183. Epub 2016 Nov 1.

PMID:
27801535
41.

The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study.

Erro R, Picillo M, Vitale C, Amboni M, Moccia M, Santangelo G, Pellecchia MT, Barone P.

Eur J Neurol. 2016 Nov;23(11):1673-1679. doi: 10.1111/ene.13106. Epub 2016 Jul 20.

PMID:
27435448
42.

Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study.

Pellecchia MT, Savastano R, Moccia M, Picillo M, Siano P, Erro R, Vallelunga A, Amboni M, Vitale C, Santangelo G, Barone P.

J Neural Transm (Vienna). 2016 Dec;123(12):1399-1402. doi: 10.1007/s00702-016-1622-6. Epub 2016 Sep 28.

PMID:
27682634
43.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Lanzillo R, Moccia M, Laplaud DA, Foucher Y.

Neurology. 2016 Sep 6;87(10):1066. doi: 10.1212/01.wnl.0000497026.62085.8d. No abstract available.

PMID:
27597557
44.

Impulsive-compulsive behaviors in parkin-associated Parkinson disease.

Morgante F, Fasano A, Ginevrino M, Petrucci S, Ricciardi L, Bove F, Criscuolo C, Moccia M, De Rosa A, Sorbera C, Bentivoglio AR, Barone P, De Michele G, Pellecchia MT, Valente EM.

Neurology. 2016 Oct 4;87(14):1436-1441. Epub 2016 Sep 2.

45.

Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned.

Heinzel S, Roeben B, Ben-Shlomo Y, Lerche S, Alves G, Barone P, Behnke S, Berendse HW, Bloem BR, Burn D, Dodel R, Grosset DG, Hu M, Kasten M, Krüger R, Moccia M, Mollenhauer B, Oertel W, Suenkel U, Walter U, Wirdefeldt K, Liepelt-Scarfone I, Maetzler W, Berg D.

Front Aging Neurosci. 2016 Jun 22;8:147. doi: 10.3389/fnagi.2016.00147. eCollection 2016. Review.

46.

White matter changes and the development of motor phenotypes in de novo Parkinson's Disease.

Moccia M, Tedeschi E, Ugga L, Erro R, Picillo M, Caranci F, Barone P, Brunetti A.

J Neurol Sci. 2016 Aug 15;367:215-9. doi: 10.1016/j.jns.2016.06.015. Epub 2016 Jun 8.

PMID:
27423590
47.

Predictors of the 10-year direct costs for treating multiple sclerosis.

Moccia M, Palladino R, Lanzillo R, Triassi M, Brescia Morra V.

Acta Neurol Scand. 2017 May;135(5):522-528. doi: 10.1111/ane.12630. Epub 2016 Jun 29.

48.

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.

Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D.

Front Aging Neurosci. 2016 May 27;8:121. doi: 10.3389/fnagi.2016.00121. eCollection 2016. No abstract available.

49.

Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease.

Moccia M, Pellecchia MT, Spina E, Barone P, Vitale C.

Cell Biochem Biophys. 2016 Jun;74(2):91-2. doi: 10.1007/s12013-015-0717-2. No abstract available.

PMID:
27286855
50.

The Dress: Transforming a web viral event into a scientific survey.

Moccia M, Lavorgna L, Lanzillo R, Brescia Morra V, Tedeschi G, Bonavita S.

Mult Scler Relat Disord. 2016 May;7:41-6. doi: 10.1016/j.msard.2016.03.001. Epub 2016 Mar 4.

PMID:
27237755

Supplemental Content

Loading ...
Support Center